AIDX
20/20 Biolabs Inc
AIDX
Closed
$0.59
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The firm offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.
Key stats
Open
$0.59
Volume
44.79K
Market cap
$7.15M
Prev. close
$0.56
Impl / hst vl
-
Open interest
$0.00
$0.59
Day’s Range
$0.60
$0.40
52W Range
$20.66
Valuation
50
Valuation score
Fairly Valued
P/E
-
P/S
-
P/B
2.26
Current ratio
1.99
Debt / Equity
-1.44
ROE
-
Gross margin
41.71%
Income growth
29.81%
FCF growth
-52.64
Analysts estimates
Consensus rating
Buy
The average rating from top 4 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$5.10
The top 3 analysts forecasts that 12-month price may increase by 764.41%, with a low of $5.05 and a high of $5.25
$5.05
Low
$5.10
Avg
$5.25
High
Current price
Earnings
Q2 ‘26 revenue
$730.60K
Q2 ‘26 net income
-$2.75M
Revenue
Net income
Previous EPS
-Estimate EPS
-$0.12
Actual EPS
Estimate EPS
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply